Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Bioproduction
Avantor’s Dr. Ger Brophy on the future of bioproduction in the cell and gene therapy space
